Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association May 16, 2019 10:02am EDT
Aptose Announces Commencement of Previously Announced $20.0 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC May 10, 2019 7:24pm EDT
Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2019 Apr 24, 2019 7:30am EDT
Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019 Apr 23, 2019 7:30am EDT
